Search Results - Stephan Stilgenbauer

Refine Results
  1. 1

    Response to Comment by Jonathan Weiss et al. by Eugen Tausch, Stephan Stilgenbauer

    Published in Haematologica (2019-11-01)
    Get full text
    Article


  2. 2

    BIRC3 mutations in chronic lymphocytic leukemia – uncommon and unfavorable by Eugen Tausch, Stephan Stilgenbauer

    Published in Haematologica (2020-02-01)
    Get full text
    Article


  3. 3

    Biological diversity and risk-adapted treatment of chronic lymphocytic leukemia by Thorsten Zenz, Daniel Mertens, Stephan Stilgenbauer

    Published in Haematologica (2010-09-01)
    Get full text
    Article


  4. 4

    Chronic lymphocytic leukemia – genomics lead the way by Daniel Mertens, Lars Bullinger, Stephan Stilgenbauer

    Published in Haematologica (2011-10-01)
    Get full text
    Article


  5. 5

    From Biology to Therapy: The CLL Success Story by Deyan Y. Yosifov, Christine Wolf, Stephan Stilgenbauer, Daniel Mertens

    Published in HemaSphere (2019-04-01)
    Get full text
    Article


  6. 6

    repDilPCR: a tool for automated analysis of qPCR assays by the dilution-replicate method by Deyan Yordanov Yosifov, Michaela Reichenzeller, Stephan Stilgenbauer, Daniel Mertens

    Published in BMC Bioinformatics (2024-10-01)
    Get full text
    Article


  7. 7

    Genotyping from targeted NGS data based on a small set of SNPs correctly matches patient samples by Deyan Yordanov Yosifov, Christof Schneider, Stephan Stilgenbauer, Daniel Mertens, Eugen Tausch

    Published in BMC Research Notes (2025-07-01)
    Get full text
    Article


  8. 8

    Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2 by Angela Schulz, Grischa Toedt, Thorsten Zenz, Stephan Stilgenbauer, Peter Lichter, Martina Seiffert

    Published in Haematologica (2011-03-01)
    Get full text
    Article


  9. 9

    The MDM2 –309 T/G promoter single nucleotide polymorphism does not alter disease characteristics in chronic lymphocytic leukemia by Thorsten Zenz, Sonja Häbe, Axel Benner, Dirk Kienle, Hartmut Döhner, Stephan Stilgenbauer

    Published in Haematologica (2008-07-01)
    Get full text
    Article


  10. 10

    TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics by Elias Campo, Florence Cymbalista, Paolo Ghia, Ulrich Jäger, Sarka Pospisilova, Richard Rosenquist, Anna Schuh, Stephan Stilgenbauer

    Published in Haematologica (2018-12-01)
    Get full text
    Article


  11. 11

    Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice by Bola S. Hanna, Haniyeh Yazdanparast, Yasmin Demerdash, Philipp M. Roessner, Ralph Schulz, Peter Lichter, Stephan Stilgenbauer, Martina Seiffert

    Published in Haematologica (2020-03-01)
    Get full text
    Article


  12. 12

    Simultaneous Inhibition of PI3Kgamma and PI3Kdelta Deteriorates T-cell Function With Implications for Chronic Lymphocytic Leukemia by Sebastian Faehling, Mariana Coelho, Alessia Floerchinger, Christof Schneider, Stephan Stilgenbauer, Peter Lichter, Martina Seiffert, Philipp M. Roessner

    Published in HemaSphere (2023-03-01)
    Get full text
    Article


  13. 13

    TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11q by Angela Garding, Nupur Bhattacharya, Sarah Haebe, Frederike Müller, Dieter Weichenhan, Irina Idler, Katja Ickstadt, Stephan Stilgenbauer, Daniel Mertens

    Published in Haematologica (2013-02-01)
    Get full text
    Article


  14. 14

    Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia by Eugen Tausch, William Close, Anna Dolnik, Johannes Bloehdorn, Brenda Chyla, Lars Bullinger, Hartmut Döhner, Daniel Mertens, Stephan Stilgenbauer

    Published in Haematologica (2019-09-01)
    Get full text
    Article


  15. 15

    Overall survival outcomes with first‐line continuous ibrutinib and fixed‐duration ibrutinib‐venetoclax treatments in patients with chronic lymphocytic leukemia: Comparison with an... by Paolo Ghia, Loic Ysebaert, Ann Janssens, Stephan Stilgenbauer, Mohamed Fouad, Claudio A. Schioppa, José‐Ángel Hernández‐Rivas, Alessandra Tedeschi

    Published in HemaSphere (2025-10-01)
    Get full text
    Article


  16. 16

    Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival by Stephan Stilgenbauer, Sandrine Sander, Lars Bullinger, Axel Benner, Elke Leupolt, Dirk Winkler, Alexander Kröber, Dirk Kienle, Peter Lichter, Hartmut Döhner

    Published in Haematologica (2007-09-01)
    Get full text
    Article


  17. 17

    Krüppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by inhibition of NOTCH signaling by Katharina Filarsky, Angela Garding, Natalia Becker, Christine Wolf, Manuela Zucknick, Rainer Claus, Dieter Weichenhan, Christoph Plass, Hartmut Döhner, Stephan Stilgenbauer, Peter Lichter, Daniel Mertens

    Published in Haematologica (2016-06-01)
    Get full text
    Article


  18. 18

    Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials by Valentin Goede, Paula Cramer, Raymonde Busch, Manuela Bergmann, Martina Stauch, Georg Hopfinger, Stephan Stilgenbauer, Hartmut Döhner, Anne Westermann, Clemens M. Wendtner, Barbara Eichhorst, Michael Hallek

    Published in Haematologica (2014-06-01)
    Get full text
    Article


  19. 19

    Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy by Marc Zapatka, Eugen Tausch, Selcen Öztürk, Deyan Yordanov Yosifov, Martina Seiffert, Thorsten Zenz, Christof Schneider, Johannes Blöhdorn, Hartmut Döhner, Daniel Mertens, Peter Lichter, Stephan Stilgenbauer

    Published in Haematologica (2021-03-01)
    Get full text
    Article


  20. 20

    Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia by Dirk Kienle, Axel Benner, Carolin Läufle, Dirk Winkler, Christof Schneider, Andreas Bühler, Thorsten Zenz, Annett Habermann, Ulrich Jäger, Peter Lichter, Riccardo Dalla-Favera, Hartmut Döhner, Stephan Stilgenbauer

    Published in Haematologica (2010-01-01)
    Get full text
    Article


Search Tools: